Machinery & Materials
Logistics & Cold Chain
More from GlobalData
Medical device packaging
Medical Device Excise Tax Suspension to Rejuvenate U.S. Market
GlobalData analyst says two-year suspension will provide relief to small- and medium-sized device makers.
Jan 25th, 2016
Top 30 pharmaceutical firms spent $112 billion on R&D in 2013
Advancing pipeline programs into later-stage clinical trials boosts spending, but many companies reduced their workforces to help stabilize profits in the aftermath of patent losses.
Dec 18th, 2014
Patent cliff to cause $65 billion sales loss
Expiries of leading drugs to cause huge financial losses for pharmaceutical firms by 2019, predicts GlobalData.
Dec 10th, 2014
Public-private partnerships vital to advanced Ebola treatment pipeline
GlobalData analyst says the infection has not represented an attractive investment for pharmaceutical companies.
Oct 16th, 2014
Biosimilars to erode biologics market beyond 2019
GlobalData report says patent expirations of branded biologics and regulatory changes will help biosimilars gain market share from biologics.
Jun 12th, 2014
Determining the future of EU medical device regulations
Device makers, lawmakers convene at Feb. 26 European Parliament committee meeting.
Feb 25th, 2013
Poor Healthcare Policies and Infrastructure, but India's Pharma Market Continues to Boom
India has numerous healthcare problems, ranging from inadequate policy monitoring to the widespread lack of health insurance, but a potentially huge, unsaturated market will see the country's pharmaceutical industry continue to expand rapidly in the coming years, predicts the latest study by market analysts GlobalData.
Aug 22nd, 2012
Medical Discoveries are Contracted Out as Research Organizations Move Abroad
Medical devices companies are outsourcing more and more of their research and development processes, reducing costs and time by conducting overseas trials, according to healthcare experts GlobalData.
Jun 8th, 2012
Supreme Court Clears the Way for Generic Patent Challenges
The United States Supreme Court this week handed down another decision affecting patent law in biotechnology.
Apr 20th, 2012